Accuri Reels in $4M in New Investments

The cytometry tools company netted the Series D funds from Fidelity, Flagship, Baird, Arboretum, and a Michigan program.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.